Osteosarcoma: all 446 studies
Page 5 of 5. Open to participants first (117), then studies with results posted, then the rest; newest registration first within each.
- Mifamurtide (L-MTP-PE) for High-Risk OsteosarcomaCompletedNCT00631631
- Inheritance of Osteosarcoma & Paget's Disease Through Chromosome 18:TerminatedNCT00615628
- Huntsman Biopsy StudyTerminatedNCT00615329
- Detection of Circulating Osteosarcoma Tumor Cells in the Blood of Patients Using the Polymerase Chain ReactionCompletedNCT00588510
- Chemotherapy Resistance in Osteogenic Sarcoma and Other Solid TumorsActive, not recruitingNCT00580385Not applicable
- Cytogenetic and Molecular Genetic Studies in Bone SarcomasCompletedNCT00579930
- Phase II Study of Intravenous Rexin-G in OsteosarcomaCompletedNCT00572130Phase 2
- Ridaforolimus in Treatment of Sarcoma-SUCCEED (Sarcoma Multi-Center Clinical Evaluation of the Efficacy of Ridaforolimus)(8669-011 AM6)CompletedNCT00538239Phase 3
- Recombinant Interferon Alpha and Etoposide in Relapsed OsteosarcomaCompletedNCT00504140Phase 2
- Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the LungCompletedNCT00503295Phase 2
- Cyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerTerminatedNCT00499733Early Phase 1
- Combined Chemotherapy With or Without Zoledronic Acid for Patients With OsteosarcomaActive, not recruitingNCT00470223Phase 3
- HGS-ETR2 to Treat Children With Solid TumorsTerminatedNCT00428272Phase 1
- Clinical Studies of Gemcitabine-OxaliplatinCompletedNCT00407433Phase 2
- Ixabepilone in Treating Young Patients With Refractory Solid TumorsCompletedNCT00331643Phase 2
- Genetic Characterisation of High-grade Paediatric OsteosarcomasCompletedNCT00223184
- Recombinant Human Thrombopoietin in Children Receiving Ifosfamide, Carboplatin, and Etoposide ChemotherapyCompletedNCT00187109Phase 1/2
- Study of Vinorelbine and Cyclofosfamide Among Patients With Refractory Tumours or in RelapseStatus unknownNCT00180947Phase 2
- Comparison of High-Dose Methotrexate (HDM) Plus Doxorubicin to HDM Plus Etoposide-Ifosfamide in Osteosarcoma ChildrenCompletedNCT00180908Phase 3
- Osteosarcoma1999-A Study Of Intensive Chemotherapy for OsteosarcomaCompletedNCT00145639Phase 2
- ZD1839 and Oral Irinotecan in Treating Young Patients With Refractory Solid TumorsCompletedNCT00132158Phase 1
- Methotrexate, Trimetrexate Glucuronate, and Leucovorin in Treating Patients With Refractory or Recurrent OsteosarcomaCompletedNCT00119301Phase 1
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid TumorsCompletedNCT00093821Phase 1
- Study of AP23573/MK-8669 (Ridaforolimus), A Mammalian Target of Rapamycin (mTOR) Inhibitor, in Participants With Advanced Sarcoma (MK-8669-018 AM1)(COMPLETED)CompletedNCT00093080Phase 2
- Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous TreatmentCompletedNCT00091182Phase 2
- Erlotinib and Temozolomide in Treating Young Patients With Recurrent or Refractory Solid TumorsCompletedNCT00077454Phase 1
- Liposomal Vincristine for Pediatric and Adolescent Patients With Relapsed MalignanciesCompletedNCT00038207Phase 2
- Imatinib Mesylate in Treating Patients With Advanced Soft Tissue Sarcoma or Bone SarcomaCompletedNCT00031915Phase 2
- Imatinib Mesylate in Treating Patients With Relapsed or Refractory Solid Tumors of ChildhoodCompletedNCT00030667Phase 2
- Eligibility Screening for a NCI Pediatric Oncology Branch Research StudyCompletedNCT00026780
- Chemotherapy With or Without Trastuzumab in Treating Patients With Metastatic OsteosarcomaCompletedNCT00023998Phase 2
- Vaccine Therapy in Treating Patients With Metastatic CancerCompletedNCT00020267Phase 1
- Combination Chemotherapy Before and After Surgery in Treating Patients With OsteosarcomaTerminatedNCT00019864Phase 2
- Liposomal Doxorubicin in Treating Children With Refractory Solid TumorsCompletedNCT00019630Phase 1
- Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
- Ecteinascidin 743 in Treating Patients With Previously Treated Metastatic OsteosarcomaCompletedNCT00005625Phase 2
- Trastuzumab in Treating Patients With Recurrent OsteosarcomaCompletedNCT00005033Phase 2
- 17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or SarcomaCompletedNCT00004241Phase 1
- Irinotecan in Treating Children With Refractory Solid TumorsCompletedNCT00004078Phase 2
- Combination Chemotherapy Plus Dexrazoxane in Treating Patients With Newly Diagnosed Nonmetastatic OsteosarcomaCompletedNCT00003937Phase 3
- Combination Chemotherapy and Surgery in Treating Patients With Newly Diagnosed Metastatic OsteosarcomaCompletedNCT00003776Phase 2
- Combination Chemotherapy and Surgery With or Without G-CSF in Treating Patients With OsteosarcomaCompletedNCT00002539Phase 3
- A Phase I Study of OncoLAR® (Registered Trademark) (NSC 685403) With/Without Tamoxifen in Patients With OsteosarcomaCompletedNCT00001436Phase 1
- Osteosarcoma Study #2: A Randomized Trial of Pre-Surgical Chemotherapy vs. Immediate Surgery and Adjuvant Chemotherapy in the Treatment of Non-Metastatic Osteosarcoma. A Pediatric Oncology Group Phase III StudyCompletedNCT00001217Phase 3
- A Pilot Study for the Treatment of Patients With Metastatic and High Risk Sarcomas and Primitive Neuroectodermal TumorsCompletedNCT00001209Phase 1